← Back to Clinical Trials
Recruiting NCT05709197

The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pancreatic Disease
Sponsor Radboud University Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 256
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-04-17
Completion 2025-09
Interventions
Braun anastomosisStandard Child reconstruction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial (REMBRANDT) is to evaluate the effectiveness of adding an extra connection (i.e. 'Braun anastomosis') after standard reconstruction in pancreatic head resection in reducing the incidence of delayed gastric emptying.

Eligibility Criteria

Inclusion Criteria: * Undergoing open pancreatoduodenectomy * Provided informed consent * Age over 18 years Exclusion Criteria: * Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires in Dutch hospitals * Previous bariatric surgery (such as Roux-en-Y gastric bypass, gastric sleeve) * Pregnancy * Bowel motility disorders * Minimally invasive pancreatoduodenectomy * Gastric outlet syndrome

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PANCREATIC DISEASE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}